articleBiofabricationJan 12, 2016GOLD OA

A liver-on-a-chip platform with bioprinted hepatic spheroids

Harvard University · Brigham and Women's Hospital · +7 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

The inadequacy of animal models in correctly predicting drug and biothreat agent toxicity in humans has resulted in a pressing need for in vitro models that can recreate the in vivo scenario. One of the most important organs in the assessment of drug toxicity is liver. Here, we report the development of a liver-on-a-chip platform for long-term culture of three-dimensional (3D) human HepG2/C3A spheroids for drug toxicity assessment. The bioreactor design allowed for in situ monitoring of the culture environment by enabling direct access to the hepatic construct during the experiment without compromising the platform operation. The engineered bioreactor could be interfaced with a bioprinter to fabricate 3D…

No related works found for this paper.

Funding